Multicentric Clinical Study on Isatis TF Trifocal Intraocular Lens
Multicentric Clinical Study to Determine Safety and Efficacy of a Hydrophobic Acrylic Trifocal Intraocular Lens (IOL)
Sponsor: Cutting Edge SAS
This NA trial investigates Cataract and Lens Opacities and is currently completed. Cutting Edge SAS leads this study, which shows 14 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Mar 2025 — Sep 2025 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2024 — Mar 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 9 earlier versions
-
Oct 2023 — Jul 2024 [monthly]
Recruiting NA
-
Jan 2023 — Oct 2023 [monthly]
Recruiting NA
-
Dec 2021 — Jan 2023 [monthly]
Recruiting NA
-
Sep 2021 — Dec 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Not Yet Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Sep 2020 — Oct 2020 [monthly]
Not Yet Recruiting NA
-
Aug 2020 — Sep 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cutting Edge SAS
- targomedGmbH
For direct contact, visit the study record on ClinicalTrials.gov .